The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.

Beatriz-Teresita Martín-MárquezMinoru SatohRogelio Hernández-PandoErika Aurora Martínez-GarcíaMarcelo Heron PetriFlavio Sandoval-GarcíaOscar-Enrique Pizano-MartínezTrinidad García-IglesiasFernanda Isadora Corona-MerazMónica Vázquez-Del Mercado

Published in: PloS one (2021)

The prophylactic co-vaccination of IL-10 with D2 in pristane-induced lupus ameliorates the renal damage maybe by acting as prophylactic DNA tolerizing therapy.

Keyphrases

systemic lupus erythematosus
circulating tumor
cell free
disease activity
single molecule
stem cells
rheumatoid arthritis
nucleic acid
cell therapy
circulating tumor cells